Eric Leire

Dr. Eric Leire brings to the Company a solid biotechnology expertise through his experience pharmaceutical industry experience (Pfizer, Schering Plough, Pharmacia), biotechnology (CEO of several private and public biotech companies such as APT Therapeutics, Paringenix), academia (Research Associate at the Harvard AIDS Institute) and Private Equity (partner at Biofund Venture Capital).

He is the inventor of several medical patents. He also serves on the board of several biotechnology companies (Immunethep, BSIM, Inhatarget). Furthermore, Dr Eric has been CEO of several gene and cell therapy companies such as Enochian Biosciences (Nasdaq: ENOB) and DanDrit Biotechnologies (OTC.QB:DDRT). He holds an MD from Grenoble University and an MBA from HEC, Paris and Kellogg, Northwestern University.